FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

THURSDAY, Nov. 13, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-